GL1X · GenesisL1 explorer

MolNFT v1 · #22138 · protein

Apo-core-streptavidin in complex with biotin (two unoccupied binding sites) at pH 4.5

1SWD: “Apo-core-streptavidin in complex with biotin (two unoccupied binding sites) at pH 4.5”. X-ray diffraction, 1 ligand (BTN), 7 pockets (best druggability 0.60). MolNFT v1 #22138 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
1SWD
Type
protein
Length
464 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Streptavidin
UniProt
P22629
Ligands
BTN
Pockets
7 · best druggability 0.60

Structure

x-ray diffraction · 4 distinct chains · 6% helix, 58% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AStreptavidinprotein1173% helix, 57% strandP22629
BStreptavidinprotein1148% helix, 57% strandP22629
CStreptavidinprotein1158% helix, 58% strandP22629
DStreptavidinprotein1185% helix, 58% strandP22629

Ligands and binding sites

  • BTN · Biotin · ligand · 2 copies · chains A, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13460.600.7741empty
21300.580.8327BTN
31100.580.8525BTN
41790.560.8022empty
51590.560.8227empty

Interfaces

6 interfaces between chains.

  • C–D · 1660 Ų buried · 27 hydrogen bonds · protein-protein
  • A–B · 1581 Ų buried · 30 hydrogen bonds · protein-protein
  • A–D · 544 Ų buried · 3 hydrogen bonds · protein-protein
  • B–C · 406 Ų buried · 4 hydrogen bonds · protein-protein
  • B–D · 201 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 1SWD · Apo-core-streptavidin in complex with biotin (two unoccupied binding sites) at pH 4.5 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.